1. Home
  2. HALO vs PRI Comparison

HALO vs PRI Comparison

Compare HALO & PRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$74.99

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Logo Primerica Inc.

PRI

Primerica Inc.

HOLD

Current Price

$283.80

Market Cap

8.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
HALO
PRI
Founded
1998
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
8.5B
IPO Year
2001
2009

Fundamental Metrics

Financial Performance
Metric
HALO
PRI
Price
$74.99
$283.80
Analyst Decision
Buy
Hold
Analyst Count
11
4
Target Price
$78.64
$294.00
AVG Volume (30 Days)
1.6M
214.6K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
1.72%
EPS Growth
N/A
67.10
EPS
1.22
5.97
Revenue
$151,862,000.00
$3,291,713,000.00
Revenue This Year
$28.24
$3.98
Revenue Next Year
$12.56
$5.08
P/E Ratio
$59.53
$47.14
Revenue Growth
N/A
6.56
52 Week Low
$51.06
$230.09
52 Week High
$82.22
$288.03

Technical Indicators

Market Signals
Indicator
HALO
PRI
Relative Strength Index (RSI) 66.87 57.64
Support Level $62.53 $255.20
Resistance Level $79.50 $284.59
Average True Range (ATR) 2.20 5.26
MACD 0.30 0.70
Stochastic Oscillator 84.09 76.08

Price Performance

Historical Comparison
HALO
PRI

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About PRI Primerica Inc.

Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.

Share on Social Networks: